Id |
Subject |
Object |
Predicate |
Lexical cue |
T8813 |
0-4 |
JJS |
denotes |
Most |
T48684 |
5-13 |
NNS |
denotes |
patients |
T37814 |
14-21 |
VBP |
denotes |
develop |
T41895 |
22-32 |
NNS |
denotes |
antibodies |
T32237 |
33-40 |
IN |
denotes |
against |
T55833 |
41-44 |
DT |
denotes |
the |
T23466 |
45-47 |
NN |
denotes |
NP |
T51386 |
48-51 |
CC |
denotes |
and |
T97267 |
52-55 |
NN |
denotes |
RBD |
T48238 |
56-58 |
IN |
denotes |
of |
T17626 |
59-68 |
NN |
denotes |
2019-nCoV |
T87676 |
69-75 |
IN |
denotes |
during |
T56543 |
76-79 |
DT |
denotes |
the |
T74019 |
80-86 |
JJ |
denotes |
second |
T36179 |
87-91 |
NN |
denotes |
week |
T61939 |
92-97 |
IN |
denotes |
after |
T53819 |
98-107 |
NN |
denotes |
infection |
T47949 |
108-113 |
NN |
denotes |
onset |
T10621 |
114-115 |
-LRB- |
denotes |
[ |
T31327 |
115-117 |
CD |
denotes |
22 |
T53799 |
117-118 |
-RRB- |
denotes |
] |
T76985 |
120-128 |
NN |
denotes |
Analysis |
T6758 |
129-131 |
IN |
denotes |
of |
T88720 |
132-137 |
NN |
denotes |
serum |
T73739 |
138-145 |
NNS |
denotes |
samples |
T20072 |
146-155 |
VBD |
denotes |
collected |
T30704 |
156-158 |
CD |
denotes |
14 |
T66398 |
159-161 |
CC |
denotes |
or |
T43796 |
162-166 |
JJR |
denotes |
more |
T64515 |
167-171 |
NNS |
denotes |
days |
T88119 |
172-177 |
IN |
denotes |
after |
T33297 |
178-185 |
NN |
denotes |
symptom |
T78997 |
186-191 |
NN |
denotes |
onset |
T69102 |
192-200 |
VBD |
denotes |
revealed |
T51393 |
201-210 |
NN |
denotes |
detection |
T49412 |
211-213 |
IN |
denotes |
of |
T86080 |
214-217 |
NN |
denotes |
IgG |
T42365 |
218-221 |
CC |
denotes |
and |
T24248 |
222-225 |
NN |
denotes |
IgM |
T84785 |
226-236 |
NNS |
denotes |
antibodies |
T33598 |
237-244 |
IN |
denotes |
against |
T65176 |
245-247 |
NN |
denotes |
NP |
T29543 |
248-250 |
IN |
denotes |
in |
T67075 |
251-253 |
CD |
denotes |
94 |
T4274 |
253-254 |
NN |
denotes |
% |
T73088 |
255-258 |
CC |
denotes |
and |
T74097 |
259-261 |
CD |
denotes |
88 |
T71868 |
261-262 |
NN |
denotes |
% |
T54079 |
263-266 |
CC |
denotes |
and |
T73098 |
267-270 |
NN |
denotes |
RBD |
T69539 |
271-273 |
IN |
denotes |
in |
T87988 |
274-277 |
CD |
denotes |
100 |
T78691 |
277-278 |
NN |
denotes |
% |
T18580 |
279-282 |
CC |
denotes |
and |
T46489 |
283-285 |
CD |
denotes |
94 |
T64615 |
285-286 |
NN |
denotes |
% |
T60810 |
287-292 |
IN |
denotes |
among |
T38563 |
293-301 |
NNS |
denotes |
patients |
T93829 |
302-306 |
IN |
denotes |
with |
T24980 |
307-314 |
NN |
denotes |
COVID19 |
T89545 |
316-323 |
NNS |
denotes |
Studies |
T44838 |
324-336 |
RB |
denotes |
consistently |
T54246 |
337-341 |
VBP |
denotes |
show |
T20581 |
342-346 |
IN |
denotes |
that |
T54967 |
347-356 |
VBN |
denotes |
increased |
T27422 |
357-371 |
NN |
denotes |
immunoglobulin |
T48431 |
372-378 |
NNS |
denotes |
levels |
T7060 |
379-388 |
VBP |
denotes |
accompany |
T92743 |
389-392 |
DT |
denotes |
the |
T24866 |
393-403 |
NN |
denotes |
transition |
T9522 |
404-408 |
IN |
denotes |
from |
T69120 |
409-414 |
JJ |
denotes |
early |
T81312 |
415-417 |
TO |
denotes |
to |
T7048 |
418-422 |
JJ |
denotes |
late |
T25388 |
423-429 |
NN |
denotes |
course |
T44741 |
430-432 |
IN |
denotes |
of |
T20679 |
433-440 |
NN |
denotes |
COVID19 |
T6735 |
442-444 |
PRP |
denotes |
It |
T32751 |
445-450 |
VBZ |
denotes |
poses |
T41840 |
451-454 |
DT |
denotes |
the |
T21434 |
455-466 |
NN |
denotes |
possibility |
T75450 |
467-471 |
IN |
denotes |
that |
T55251 |
472-476 |
NN |
denotes |
IVIG |
T48129 |
477-484 |
NN |
denotes |
therapy |
T90120 |
485-490 |
MD |
denotes |
might |
T91321 |
491-495 |
VB |
denotes |
help |
T89890 |
496-498 |
TO |
denotes |
to |
T64443 |
499-509 |
VB |
denotes |
accelerate |
T5150 |
510-518 |
NN |
denotes |
recovery |
T43666 |
519-523 |
IN |
denotes |
from |
T85289 |
524-532 |
NN |
denotes |
COVID-19 |
R10059 |
T24866 |
T92743 |
arg1Of |
transition,the |
R11280 |
T7048 |
T69120 |
arg1Of |
late,early |
R11593 |
T25388 |
T9522 |
arg2Of |
course,from |
R13100 |
T41895 |
T37814 |
arg2Of |
antibodies,develop |
R13579 |
T5150 |
T43666 |
arg1Of |
recovery,from |
R15007 |
T84785 |
T49412 |
arg2Of |
antibodies,of |
R15150 |
T48431 |
T54967 |
arg2Of |
levels,increased |
R15728 |
T78691 |
T18580 |
arg1Of |
%,and |
R16578 |
T20679 |
T44741 |
arg2Of |
COVID19,of |
R17029 |
T86080 |
T42365 |
arg1Of |
IgG,and |
R17888 |
T21434 |
T41840 |
arg1Of |
possibility,the |
R18045 |
T48684 |
T8813 |
arg1Of |
patients,Most |
R1890 |
T7060 |
T20581 |
arg1Of |
accompany,that |
R20807 |
T51386 |
T32237 |
arg2Of |
and,against |
R22109 |
T23466 |
T51386 |
arg1Of |
NP,and |
R2585 |
T36179 |
T74019 |
arg1Of |
week,second |
R27595 |
T24866 |
T7060 |
arg2Of |
transition,accompany |
R27615 |
T48129 |
T64443 |
arg1Of |
therapy,accelerate |
R29116 |
T51393 |
T29543 |
arg1Of |
detection,in |
R29180 |
T69102 |
T88119 |
arg2Of |
revealed,after |
R30440 |
T48129 |
T90120 |
arg1Of |
therapy,might |
R30751 |
T78997 |
T69102 |
arg1Of |
onset,revealed |
R30825 |
T71868 |
T54079 |
arg1Of |
%,and |
R31087 |
T64515 |
T30704 |
arg1Of |
days,14 |
R31620 |
T4274 |
T67075 |
arg1Of |
%,94 |
R32415 |
T4274 |
T73088 |
arg1Of |
%,and |
R3294 |
T31327 |
T10621 |
arg2Of |
22,[ |
R33556 |
T47949 |
T53819 |
arg1Of |
onset,infection |
R34056 |
T48129 |
T55251 |
arg1Of |
therapy,IVIG |
R34363 |
T37814 |
T61939 |
arg1Of |
develop,after |
R35220 |
T84785 |
T86080 |
arg1Of |
antibodies,IgG |
R35461 |
T36179 |
T87676 |
arg2Of |
week,during |
R35710 |
T37814 |
T32237 |
arg1Of |
develop,against |
R36223 |
T24248 |
T42365 |
arg2Of |
IgM,and |
R36970 |
T25388 |
T7048 |
arg1Of |
course,late |
R37373 |
T51393 |
T33598 |
arg1Of |
detection,against |
R38001 |
T51393 |
T60810 |
arg1Of |
detection,among |
R39248 |
T64443 |
T89890 |
arg1Of |
accelerate,to |
R41074 |
T71868 |
T4274 |
arg1Of |
%,% |
R41127 |
T89545 |
T54246 |
arg1Of |
Studies,show |
R41612 |
T5150 |
T64443 |
arg2Of |
recovery,accelerate |
R42305 |
T64615 |
T46489 |
arg1Of |
%,94 |
R4510 |
T91321 |
T75450 |
arg1Of |
help,that |
R46659 |
T91321 |
T90120 |
arg2Of |
help,might |
R46687 |
T47949 |
T61939 |
arg2Of |
onset,after |
R48701 |
T30704 |
T43796 |
arg1Of |
14,more |
R4871 |
T84785 |
T24248 |
arg1Of |
antibodies,IgM |
R52555 |
T7060 |
T54246 |
arg2Of |
accompany,show |
R53047 |
T74097 |
T73088 |
arg2Of |
88,and |
R54593 |
T38563 |
T93829 |
arg1Of |
patients,with |
R58487 |
T30704 |
T66398 |
arg1Of |
14,or |
R59227 |
T64443 |
T91321 |
arg2Of |
accelerate,help |
R60224 |
T71868 |
T74097 |
arg1Of |
%,88 |
R61089 |
T7048 |
T81312 |
arg1Of |
late,to |
R61094 |
T78997 |
T33297 |
arg1Of |
onset,symptom |
R6445 |
T24980 |
T93829 |
arg2Of |
COVID19,with |
R64474 |
T76985 |
T20072 |
arg1Of |
Analysis,collected |
R64970 |
T24866 |
T9522 |
arg1Of |
transition,from |
R67370 |
T64615 |
T78691 |
arg1Of |
%,% |
R6800 |
T51386 |
T55833 |
arg1Of |
and,the |
R68469 |
T21434 |
T32751 |
arg2Of |
possibility,poses |
R6993 |
T37814 |
T10621 |
arg1Of |
develop,[ |
R71902 |
T91321 |
T21434 |
arg2Of |
help,possibility |
R72949 |
T73739 |
T6758 |
arg2Of |
samples,of |
R73124 |
T78691 |
T87988 |
arg1Of |
%,100 |
R74727 |
T54079 |
T29543 |
arg2Of |
and,in |
R74845 |
T46489 |
T18580 |
arg2Of |
94,and |
R76248 |
T25388 |
T44741 |
arg1Of |
course,of |
R78306 |
T53799 |
T10621 |
arg3Of |
],[ |
R79272 |
T48431 |
T27422 |
arg1Of |
levels,immunoglobulin |
R79737 |
T64515 |
T20072 |
arg2Of |
days,collected |
R80609 |
T65176 |
T33598 |
arg2Of |
NP,against |
R80924 |
T85289 |
T43666 |
arg2Of |
COVID-19,from |
R81797 |
T97267 |
T51386 |
arg2Of |
RBD,and |
R85646 |
T51393 |
T69102 |
arg2Of |
detection,revealed |
R86911 |
T54246 |
T44838 |
arg1Of |
show,consistently |
R87740 |
T17626 |
T48238 |
arg2Of |
2019-nCoV,of |
R8876 |
T37814 |
T87676 |
arg1Of |
develop,during |
R89986 |
T38563 |
T60810 |
arg2Of |
patients,among |
R91116 |
T20072 |
T88119 |
arg1Of |
collected,after |
R91140 |
T51386 |
T48238 |
arg1Of |
and,of |
R91845 |
T48684 |
T37814 |
arg1Of |
patients,develop |
R92508 |
T73098 |
T54079 |
arg2Of |
RBD,and |
R93295 |
T6735 |
T32751 |
arg1Of |
It,poses |
R94093 |
T73739 |
T88720 |
arg1Of |
samples,serum |
R94505 |
T48129 |
T91321 |
arg1Of |
therapy,help |
R94930 |
T51393 |
T49412 |
arg1Of |
detection,of |
R9744 |
T64615 |
T69539 |
arg2Of |
%,in |
R97441 |
T36179 |
T56543 |
arg1Of |
week,the |
R98284 |
T76985 |
T6758 |
arg1Of |
Analysis,of |
R99739 |
T54079 |
T69539 |
arg1Of |
and,in |
R9994 |
T48431 |
T7060 |
arg1Of |
levels,accompany |